Last updated: April 18, 2024
Sponsor: Seoul National University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autonomic Nervous System
Treatment
Lateral lumbar interbody fusion
Clinical Study ID
NCT04891432
2101-142-1191
Ages 20-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with lumbar degenerative disease needs a lateral lumbar interbody fusion of 1-2 segments between L2 to S1.
Exclusion
Exclusion Criteria:
- Patients who had previously had lumbar surgery
- Patients with muscle weakness of motor grade III or lower
- Patients with neuropsychiatric diseases such as depression
- Patients with musculoskeletal disease, inflammatory musculoskeletal disease, orinfection
- Patients with cancerous disease
- Patients who do not want to participate in the study
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Lateral lumbar interbody fusion
Phase:
Study Start date:
April 08, 2021
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Seoul National University Hospital
Seoul, Korea 03080
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.